Background illustration for clinical trials search

Paid Clinical Trials Surprise

Discover 1,294 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

for
Myositis
Location: Glendale AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05895786

Phase 3, Recruiting

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

for
Active Rheumatoid Arthritis
Location: Glendale AZ, Gilbert AZ, Tucson AZ, Tustin CA,
Sponsor: Elevara Medicines Limited

Sex: All

Age: 18 - 70+

Code: NCT07409103

Phase 2, Recruiting

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

for
Radiographic Axial Spondyloarthritis
Location: Glendale AZ, Chandler AZ, Gilbert AZ, Flagstaff AZ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07133633

Phase 2, Recruiting

A Study of Dotinurad Versus Allopurinol in Participants With Gout

for
Gout
Location: Glendale AZ, Mesa AZ, Gilbert AZ, Tucson AZ,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089875

Phase 3, Recruiting

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for
Tophaceous Gout
Location: Glendale AZ, Mesa AZ, Gilbert AZ, Tucson AZ,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089888

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

for
Obesity, Overweight, Chronic Weight Management,
Location: Phoenix AZ, San Antonio TX, Austin TX, Evansville IN,
Sponsor: Ascletis Pharma (China) Co., Limited

Sex: All

Age: 18+

Code: NCT07743450

Phase 3, Recruiting

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Glendale AZ, Las Vegas NV, Walnut Creek CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05139017

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Glendale AZ, Bullhead City AZ, Fountain Valley CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361510

Phase 3, Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

for
Immune Thrombocytopenia
Location: Glendale AZ, Los Angeles CA, Lone Tree CO, Fairfax VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07104565

Phase 2, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Glendale AZ, Goodyear AZ, Chandler AZ, St. George UT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for
Colorectal Neoplasms
Location: Glendale AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT05253651

Phase 3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Glendale AZ, Newport Beach CA, Farmington NM,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Glendale AZ, Orange CA, Newport Beach CA, Boulder CO,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase 3, Recruiting

Non-Invasive Preeclampsia Screening and Biobank

for
Preeclampsia (PE)
Location: Glendale AZ, Austin TX, Houston TX, Galveston TX,
Sponsor: Sequenom, Inc.

Sex: Female

Age: 18+

Code: NCT06643741

Recruiting

EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)

for
Single Gene NIPT
Location: Glendale AZ, Los Angeles CA, San Carlos CA,
Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT06808880

Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Glendale AZ, Avondale AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 16+

Code: NCT06617325

Phase 3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Goodyear AZ, Chandler AZ, Gilbert AZ, San Diego CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Goodyear AZ, Phoenix AZ, Gilbert AZ, San Diego CA,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

for
Refractory Rheumatoid Arthritis (RA),
Location: Phoenix AZ, Tucson AZ, Chula Vista CA, Tustin CA,
Sponsor: Artiva Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06991114

Phase 2, Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

for
SLE, SLE (Systemic Lupus)
Location: Avondale AZ, Tucson AZ, Salt Lake City UT, Plano TX,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18 - 70

Code: NCT06613360

Phase 1, Recruiting